BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19117829)

  • 1. Antibody library-based tumor endothelial cells surface proteomic functional screen reveals migration-stimulating factor as an anti-angiogenic target.
    Hu H; Ran Y; Zhang Y; Zhou Z; Harris SJ; Yu L; Sun L; Pan J; Liu J; Lou J; Yang Z
    Mol Cell Proteomics; 2009 Apr; 8(4):816-26. PubMed ID: 19117829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.
    Sun L; Chen L; Sun L; Pan J; Yu L; Han L; Yang Z; Luo Y; Ran Y
    Mol Cell Proteomics; 2013 Feb; 12(2):395-406. PubMed ID: 23184915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth.
    Zhang Y; Ran Y; Yu L; Hu H; Zhou Z; Sun L; Lou J; Yang Z
    Anticancer Res; 2006; 26(4B):2963-70. PubMed ID: 16886621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human esophageal cancer endothelial cells increase tumor growth by incorporating with mouse endothelium.
    Hu H; Zhang Y; Ran Y; Zhou Z; Yu L; Lou J; Yang Z
    Cancer Lett; 2007 Jul; 252(1):123-30. PubMed ID: 17276590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of functional antibodies targeting tumor endothelia for the treatment of hepatic carcinoma].
    Hu H; Ran YL; Yu L; Zhou Z; Lou JN; Yang ZH
    Ai Zheng; 2007 May; 26(5):453-7. PubMed ID: 17672931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.
    Kim TK; Park CS; Jang J; Kim MR; Na HJ; Lee K; Kim HJ; Heo K; Yoo BC; Kim YM; Lee JW; Kim SJ; Kim ES; Kim DY; Cha K; Lee TG; Lee S
    Mol Oncol; 2018 Mar; 12(3):356-372. PubMed ID: 29316206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.
    Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y
    Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.
    Desselle A; Chaumette T; Gaugler MH; Cochonneau D; Fleurence J; Dubois N; Hulin P; Aubry J; Birklé S; Paris F
    PLoS One; 2012; 7(11):e45423. PubMed ID: 23189121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
    Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis.
    Brand V; Lehmann C; Umkehrer C; Bissinger S; Thier M; de Wouters M; Raemsch R; Jucknischke U; Haas A; Breuer S; Birzele F; Racek T; Reis M; Lorenzon E; Herting F; Stürzl M; Lorenz S; Kienast Y
    Mol Oncol; 2016 Dec; 10(10):1603-1620. PubMed ID: 28949445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
    Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
    Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical vein endothelial cell vaccine suppresses the angiogenesis of esophageal squamous cell carcinoma in a humanized mouse model.
    Liu H; Zhao J; Yang Y; Jin G; Zhang X; Wang D; Xie C; Liu K; Chen X; Li X; Tian F; Dong Z; Lu J
    Oncol Rep; 2018 Nov; 40(5):3006-3014. PubMed ID: 30132560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells.
    Siva AC; Kirkland RE; Lin B; Maruyama T; McWhirter J; Yantiri-Wernimont F; Bowdish KS; Xin H
    J Immunol Methods; 2008 Jan; 330(1-2):109-19. PubMed ID: 18096183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.
    Chang K; Pastan I; Willingham MC
    Int J Cancer; 1992 Feb; 50(3):373-81. PubMed ID: 1735605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of monoclonal antibody against lung cancer and identification of its targeting antigen].
    Lu Z; Song Q; Song Q; Jiang S; Yang J; Luo F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):147-51. PubMed ID: 20337043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.
    Ha KD; Bidlingmaier SM; Zhang Y; Su Y; Liu B
    Mol Cell Proteomics; 2014 Dec; 13(12):3320-31. PubMed ID: 25149096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
    Lin YC; Liu CY; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody phage display technologies with special reference to angiogenesis.
    Smith J; Kontermann RE; Embleton J; Kumar S
    FASEB J; 2005 Mar; 19(3):331-41. PubMed ID: 15746176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.
    Hara Y; Torii R; Ueda S; Kurimoto E; Ueda E; Okura H; Tatano Y; Yagi H; Ohno Y; Tanaka T; Masuko K; Masuko T
    Cancer Sci; 2018 Oct; 109(10):3171-3182. PubMed ID: 30058195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.